Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$268M |
| 3 |
Baxter International
BAX
|
+$212M |
| 4 |
UnitedHealth
UNH
|
+$185M |
| 5 |
Corteva
CTVA
|
+$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$251M |
| 4 |
Salesforce
CRM
|
+$226M |
| 5 |
Match Group
MTCH
|
+$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
SpartanNash
SPTN
$897M
| $7.31M | ﹤0.01% |
251,991
+5,055
| +2% | +$147K |
|
1652
Twist Bioscience
TWST
$1.53B
| $7.31M | ﹤0.01% |
207,540
-2,891
| -1% | -$102K |
|
1653
WideOpenWest
WOW
$442M
| $7.28M | ﹤0.01% |
593,470
-305,578
| -34% | -$3.75M |
|
1654
Evolus
EOLS
$465M
| $7.27M | ﹤0.01% |
903,141
-123,487
| -12% | -$994K |
|
1655
M/I Homes
MHO
$4.07B
| $7.25M | ﹤0.01% |
200,065
-2,249
| -1% | -$81.5K |
|
1656
Coursera
COUR
$1.8B
| $7.25M | ﹤0.01% |
672,150
-16,850
| -2% | -$182K |
|
1657
Bread Financial
BFH
$2.95B
| $7.23M | ﹤0.01% |
229,827
-7,561
| -3% | -$238K |
|
1658
QCR Holdings
QCRH
$1.3B
| $7.23M | ﹤0.01% |
141,883
+16,090
| +13% | +$820K |
|
1659
Penske Automotive Group
PAG
$11.9B
| $7.21M | ﹤0.01% |
73,263
-5,715
| -7% | -$563K |
|
1660
Nurix Therapeutics
NRIX
$691M
| $7.2M | ﹤0.01% |
552,656
+228,071
| +70% | +$2.97M |
|
1661
Innoviva
INVA
$1.22B
| $7.18M | ﹤0.01% |
618,444
-346,071
| -36% | -$4.02M |
|
1662
Axcelis
ACLS
$2.69B
| $7.17M | ﹤0.01% |
118,403
-2,128
| -2% | -$129K |
|
|
SAGE
1663
DELISTED
Sage Therapeutics
SAGE
| $7.17M | ﹤0.01% |
183,043
-3,849
| -2% | -$151K |
|
1664
ICU Medical
ICUI
$3.22B
| $7.16M | ﹤0.01% |
47,572
+3,018
| +7% | +$454K |
|
|
SLCA
1665
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $7.16M | ﹤0.01% |
653,839
-155,684
| -19% | -$1.7M |
|
1666
Editas Medicine
EDIT
$242M
| $7.15M | ﹤0.01% |
583,747
-2,153
| -0.4% | -$26.4K |
|
|
TBI
1667
Trueblue
TBI
$179M
| $7.11M | ﹤0.01% |
372,789
-44,236
| -11% | -$844K |
|
1668
Papa John's
PZZA
$1.65B
| $7.09M | ﹤0.01% |
101,281
-20,265
| -17% | -$1.42M |
|
|
BLUE
1669
DELISTED
bluebird bio
BLUE
| $7.09M | ﹤0.01% |
56,002
+39,750
| +245% | +$5.03M |
|
1670
RAPT Therapeutics
RAPT
$268M
| $7.08M | ﹤0.01% |
36,761
+23,089
| +169% | +$4.44M |
|
1671
First Financial Bancorp
FFBC
$2.46B
| $7.07M | ﹤0.01% |
335,233
-6,896
| -2% | -$145K |
|
|
AGR
1672
DELISTED
Avangrid, Inc.
AGR
| $7.06M | ﹤0.01% |
169,194
+11,513
| +7% | +$480K |
|
1673
Upbound Group
UPBD
$1.45B
| $7.05M | ﹤0.01% |
402,775
-168,118
| -29% | -$2.94M |
|
1674
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $7.01M | ﹤0.01% |
729,437
-158,148
| -18% | -$1.52M |
|
1675
WD-40
WDFC
$2.86B
| $6.96M | ﹤0.01% |
39,607
-6,093
| -13% | -$1.07M |
|